Ebola

News

First trial of Bundibugyo Ebola vaccine starts in UK

Oxford University has launched what it says is the world's first phase I trial of a vaccine specifically designed to protect against Bundibugyo Ebola.

News

Island Pharma drug cleared for Bundibugyo Ebola use

Island Pharma has been granted the approvals needed to allow compassionate use of its antiviral galidesivir in the Bundibugyo Ebola outbreak.

News

Trial of Bundibugyo Ebola drugs starts in DRC

Patients are now being enrolled in a trial of two potential therapies for Bundibugyo Ebola, Mapp's MBP134 and Gilead's remdesivir, says WHO.

News

Roche develops Bundibugyo Ebola test in six days

A PCR diagnostic developed by Roche for the Bundibugyo form of Ebola is being offered to health systems at the front lines of the current outbreak.

News

Vaccine image from University of Southampton

First human trial backs AI-designed 'universal' vaccine

An AI-powered universal vaccine tech developed by UK biotech DIOSynVax has shown preliminary efficacy in a world-first human trial.

News

CEPI puts $60m behind three Ebola vaccine candidates

Moderna has been awarded $50m from CEPI for a Bundibugyo ebolavirus vaccine candidate, with funding also made available to two other candidates.

First trial of Bundibugyo Ebola vaccine starts in UK

Island Pharma drug cleared for Bundibugyo Ebola use

Trial of Bundibugyo Ebola drugs starts in DRC

Roche develops Bundibugyo Ebola test in six days

First human trial backs AI-designed 'universal' vaccine

CEPI puts $60m behind three Ebola vaccine candidates

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

Ebola

Editor's Picks